SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 11/13/17 Elbit Imaging Ltd 20-F 12/31/16 24:8.8M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual Report by a Foreign Private Issuer HTML 2.51M 2: EX-4.10 Securities Purchase Agreement and Supplemental HTML 212K Agreement, Dated December 2, 2015 3: EX-4.12 Bank Loan Acquired by Pc, Dated December 6, 2016 HTML 46K Which Is Held Against Pc's Plot in Brasov, Romania 4: EX-4.13 Debt Repayment Agreement in Relation to Zgorzelec HTML 202K Plaza Commercial in Poland, Dated June 28, 2016 5: EX-4.14 Receivable Transfer Contract Regarding the HTML 181K Acquisition of A Loan to Control the Liberec Plaza Commercial Center, Dated March 31, 2016 6: EX-8.1 List of Subsidiaries HTML 14K 7: EX-12.1 Certifications HTML 24K 8: EX-13.1 Certifications HTML 16K 9: EX-15.1 Annual Condensed Financial Statements of the HTML 98K Company (Stand-Alone) as of December 31, 2016 and 2015 and for the Years Ended December 31, 2016, 2015 and 2014 18: EX-15.10 Consent of Greenberg Olpiner & Co. HTML 12K 19: EX-15.11 Consent of Bdo Ziv Haft Consulting and Management HTML 12K Ltd 20: EX-15.12 Consent of Variance Economic Consulting Ltd. HTML 12K 21: EX-15.13 Consent of Financial Immunities Dealing Room Ltd. HTML 12K 22: EX-15.14 Consent of Brightman Almagor Zohar & Co for the HTML 14K Company's Consolidated Financial Statements 23: EX-15.15 Consent of Brightman Almagor Zohar & Co for HTML 12K Insightec's Consolidated Financial Statements 24: EX-15.16 Consent of Kost Forer Gabbay & Kasiere for the HTML 12K Company's Consolidated Financial Statements 10: EX-15.2 Letter Addressed to SEC Pursuant to Item 16F HTML 14K 11: EX-15.3 Table of Advisors Relied Upon in the Consolidated HTML 14K Financial Statements as of December 31, 2016 for the Years Ended December 31, 2016, 2015 and 2014 12: EX-15.4 Consent of Colliers International HTML 12K 13: EX-15.5 Consent of Financial Immunities Dealing Room Ltd HTML 12K 14: EX-15.6 Consent of Cushman & Wakefield HTML 12K 15: EX-15.7 Consent of Jones Lang Lasalle Services Srl HTML 12K 16: EX-15.8 Consent of Financial Immunities Dealing Room Ltd. HTML 12K 17: EX-15.9 Consent of De Kalo Ben Yehuda & Co Ltd. HTML 12K
Exhibit 8.1
NAME OF COMPANY | COUNTRY OF ORGANIZATION | DIRECT/INDIRECT OWNERSHIP PERCENTAGE | ||
Plaza Centers N.V. | The Netherlands | 44.9% (1) | ||
Elscint Holdings & Investment N.V. | The Netherlands | 100% | ||
Elbit Medical Technologies Ltd. | Israel | 89.9% (2) | ||
Elbit Plaza India Real Estate Holdings Limited | Cyprus | 50% (3)(4) | ||
Elbit Ultrasound (Luxemburg) B.V./S.a r.l. | The Netherlands and Luxemburg | 100% |
(1) | Approximately 42.7% on a fully diluted basis. |
(2) | Approximately 85.6% on a fully diluted basis. |
(3) | We hold 47.5% of the shares in EPI directly, and an additional 47.5% through PC. For additional information as to the joint venture signed between us and PC regarding EPI, see “Item 4.B Business Overview - Plots in India.” |
(4) | 5% of the equity in EPI was allotted to Mr. Avraham (Rami) Goren who served as our former Executive vice chairman of the Board. The shares allotted are entitled to distribution only following their return of Investment of Elbit and PC plus agreed interest. |